Praedicare
Praedicare is an innovative drug development company that leverages advanced predictive AI and a unique System of Systems approach to replace traditional drug development processes. Their technology integrates physical laboratory models, digital twins, mathematical models, and clinical trial data to achieve a remarkable 94% accuracy in clinical trial forecasting, significantly outperforming traditional methods. By reducing drug development costs by up to 90% and accelerating timelines by 2-3 times, Praedicare positions itself as a leader in the market, with a proven track record of successful AI-powered drug developments and FDA/EMA approvals for 20 clients. Their approach not only enhances patient safety by reducing the number of subjects required in clinical trials but also minimizes adverse events, making them a compelling option for pharmaceutical companies looking to innovate in drug development.
Praedicare
Praedicare is an innovative drug development company that leverages advanced predictive AI and a unique System of Systems approach to replace traditional drug development processes. Their technology integrates physical laboratory models, digital twins, mathematical models, and clinical trial data to achieve a remarkable 94% accuracy in clinical trial forecasting, significantly outperforming traditional methods. By reducing drug development costs by up to 90% and accelerating timelines by 2-3 times, Praedicare positions itself as a leader in the market, with a proven track record of successful AI-powered drug developments and FDA/EMA approvals for 20 clients. Their approach not only enhances patient safety by reducing the number of subjects required in clinical trials but also minimizes adverse events, making them a compelling option for pharmaceutical companies looking to innovate in drug development.